№ files_lp_4_process_3_084158
File format: docx
Character count: 3858
File size: 27 KB
Letter providing information and requesting consent from mothers for participation in a study on birth defects, including the use of leftover newborn bloodspots and release of infectious disease results.
Year:
2021
Organization:
Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS)
Document Type:
Participant Letter
Target Audience:
Mothers of newborns
Purpose:
Request for consent to release infectious disease results and leftover newborn bloodspots
Incentive:
$10 gift card
Delivery Method:
Postal mail with pre-paid envelope
Additional Materials:
Informed consent forms for infectious disease results and leftover bloodspots
Context:
Letters include instructions for multiple or singleton births and emphasize research on genetics and birth defects
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Region / city:
Victoria, Australia
Subject:
Newborn bloodspot screening
Document type:
Policy and guideline
Organization / institution:
Victorian Department of Health
Author:
Victorian Clinical Genetics Services
Target audience:
Health care providers, parents of newborns, policy makers
Period of validity:
Ongoing
Approval date:
December 2017
Date of changes:
N/A
Year:
2019
Date:
August 13, 2019
Country:
United States
States / Regions:
Arkansas, California, Georgia, Iowa, Massachusetts, New York, North Carolina
Subject:
Birth defects surveillance and pregnancy exposure research
Type of document:
Research methodology statement
Program:
Birth Defects Study to Evaluate Pregnancy Exposures (BD-STEPS)
Organization:
Centers for Disease Control and Prevention (CDC)
Center:
National Center on Birth Defects and Developmental Disabilities (NCBDDD)
Division:
Division of Congenital and Developmental Disabilities (DCDD)
Author:
Mary Jenkins, PhD
Position:
Health Scientist
Participating Institutions:
Centers for Birth Defects Research and Prevention (CBDRP)
Data Sources:
State birth defects surveillance systems, hospital birth logs, vital records, newborn bloodspots
Respondent Groups:
Mothers of infants with birth defects, control mothers, stillbirth cases
Data Collection Methods:
Computer-assisted telephone interviews, mailed consent forms, medical record review, online questionnaires
Sample Scope:
Cases with 22 selected birth defects and randomly selected control infants
Estimated Respondents:
3,030 unique respondents annually
Research Materials:
Telephone interview questionnaire, consent forms, introductory letters, follow-up correspondence
Year:
2023
Region / City:
Not specified
Topic:
Software defects and anomalies in VBECS
Document Type:
Technical documentation
Organization:
VBECS team
Author:
VBECS team
Target audience:
VBECS users and administrators
Period of validity:
Ongoing
Approval Date:
Not specified
Change Date:
VBECS 2.3.2 updates
Version:
2.3.0
Product:
VistA Blood Establishment Computer Software (VBECS)
Document type:
Known defects and anomalies list
Scope:
System-wide and option-specific issues
Risk classification:
Acceptable risk, Minor level of concern
Assessment focus:
Patient safety and operational impact
Likelihood categories:
Frequent, Probable, Occasional, Remote, Improbable
Related documentation:
VBECS Technical Manual – Security Guide; VBECS Administrator User Guide; VBECS User Guide; VBECS Frequently Asked Questions
Intended audience:
VBECS users and administrators
System context:
Blood establishment and transfusion support software
Source type:
Internal system documentation
Document type:
Technical reference
System:
VistA Blood Establishment Computer Software (VBECS)
Subject:
Known defects and anomalies
Domain:
Blood banking software
Risk classification:
Acceptable risk with minor level of concern
Assessment framework:
Risk assessment table based on likelihood of occurrence and level of concern
Intended users:
Blood bank technologists, supervisors, administrators
Security roles covered:
Blood Bank Technologist, Enhanced Technologist, Lead Technologist, Supervisor, Administrator
Related documentation:
VBECS User Guide; VBECS Technical Manual – Security Guide
Formatting requirement:
Legal paper size (8.5 x 14 inches)
Source context:
Clinical information system for blood establishment operations
Timeframe references:
FY15, FY16 (tracking identifiers)
Note:
Year
Subject:
Building façade inspection and remedial works
Document Type:
Report
Year:
2026
Region / City:
Kansas, US
Subject:
Public Health / Birth Defects Reporting
Document Type:
Economic Impact Statement
Organization:
Kansas Department of Health and Environment
Author:
Susan Vogel
Agency Contact:
Susan Vogel
Contact Phone Number:
(785) 296-1291
K.A.R. Numbers:
28-4-520; 28-4-521
Regulation Type:
Permanent
Federal Mandate:
No
Affected Entities:
Hospitals, birthing facilities, midwives, physician offices
Implementation Costs:
None
Compliance Costs:
None
Reporting Changes:
ICD-9-CM to generalized disorder categories including NAS, exclusion of metabolic and behavioral disorders
Data Handling Updates:
Introduction of department document for ICD-10-CM codes and patient data removal procedures
Policy Alignment:
Consistent with CDC and NBDPN recommendations, aligned with contiguous states’ practices
Year:
2021
Region / City:
Australia
Topic:
Medicare Benefits Schedule, Autologous Fat Grafting, Burns Scars, Craniofacial Defects
Document Type:
Fact Sheet
Organization / Institution:
Department of Health, Medical Services Advisory Committee
Author:
Department of Health
Target Audience:
General Surgeons, Plastic Surgeons, Reconstructive Surgeons, Healthcare Providers
Effective Period:
From 1 November 2021
Approval Date:
22 September 2021
Date of Changes:
22 September 2021
Consulted Parties:
Royal Australasian College of Surgeons, Australian Society of Plastic Surgeons, Reclaim Your Curves, Breast Cancer Network Australia, Australia and New Zealand Burn Association, Consumers Health Forum Australia, General Surgeons Australia
Patient Rebate:
Medicare Rebate available
Descriptor:
MBS item 45589 for autologous fat grafting (harvesting, preparation, and injection of adipocytes)
Description:
A fact sheet detailing the creation of a new Medicare Benefits Schedule (MBS) item for autologous fat grafting, outlining its eligibility criteria, fees, and provider information.
Year:
2019
Region / City:
Glasgow, Liverpool, Newcastle upon Tyne, Newquay, Edinburgh, Glasgow
Theme:
Stroke, visual field defects, interventions, quality of life
Document Type:
Systematic review
Author:
Christine Hazelton, Pauline Campbell, Fiona J Rowe, Sven Jonuscheit, Ashleigh Kernohan, Jayne Angilley, Clair A Henderson, Peter Langhorne, Alex Pollock
Target Audience:
Healthcare professionals, researchers
Date of Approval:
2019
Date of Changes:
N/A
Funding:
Stroke Association, University of Liverpool, Royal National Institute of Blind People (RNIB)
Note:
Year
Topic:
Eye Defects
Document Type:
Medical Report
Author:
ATOGWE Victoria Aloiye
Context:
A medical report discussing two common eye defects, myopia and hyperopia, and their respective causes and corrective treatments.
Year:
2018–2023
Region / City:
Ghent, Belgium
Institution:
General hospital in Ghent
Authors:
Pieter-Jan Kellens; An De Hauwere; Sandrine Bayart; Klaus Bacher; Tom Loeys
Corresponding Author:
Pieter-Jan Kellens
Affiliation:
Health and Safety Department; Medical Physics Experts
Document Type:
Scientific research article
Subject:
Quality control of personal radiation protective equipment
Keywords:
Quality control; radiation protection; occupational safety; statistics
Study Design:
Retrospective observational study with predictive modeling
Data Period:
2018–2023
Equipment:
Siemens Luminos dRF (fluoroscopy system)
Standard Referenced:
IEC 61331-3:2014
Outcome Measure:
QC result (pass or rejected)
Predictors:
Brand; age; size; type; visual defects; department
Statistical Methods:
Logistic regression; random forests; chi-square test; ROC analysis
Rejection Criteria:
Total defect area > 670 mm² or single tear > 15 mm²
Lead Equivalence:
0.50/0.25 mm
Year:
2019
Date:
August 13, 2019
Country:
United States
States / Regions:
Arkansas, California, Georgia, Iowa, Massachusetts, New York, North Carolina
Subject:
Birth defects surveillance and pregnancy exposure research
Type of document:
Research methodology statement
Program:
Birth Defects Study to Evaluate Pregnancy Exposures (BD-STEPS)
Organization:
Centers for Disease Control and Prevention (CDC)
Center:
National Center on Birth Defects and Developmental Disabilities (NCBDDD)
Division:
Division of Congenital and Developmental Disabilities (DCDD)
Author:
Mary Jenkins, PhD
Position:
Health Scientist
Participating Institutions:
Centers for Birth Defects Research and Prevention (CBDRP)
Data Sources:
State birth defects surveillance systems, hospital birth logs, vital records, newborn bloodspots
Respondent Groups:
Mothers of infants with birth defects, control mothers, stillbirth cases
Data Collection Methods:
Computer-assisted telephone interviews, mailed consent forms, medical record review, online questionnaires
Sample Scope:
Cases with 22 selected birth defects and randomly selected control infants
Estimated Respondents:
3,030 unique respondents annually
Research Materials:
Telephone interview questionnaire, consent forms, introductory letters, follow-up correspondence
Year:
2026
Organization:
Sample Team
Document Type:
Guidelines
Audience:
Development Team, QA, Product Owner
Scope:
Agile software development process
Coverage:
Backlog items, stories, defects, tasks, sprints, releases
Approval Date:
Not specified
Revision Date:
Not specified
Includes:
Definition of Done criteria for tasks, backlog items, defects, sprints, and releases
Year:
2026
Region / City:
Oregon, USA
Subject:
Public notice requirements for water systems after coliform investigation
Document type:
Guidance / Instruction
Issuing agency:
Oregon Health Authority, Drinking Water Services
Audience:
Operators of community and non-community water systems
Applicable period:
As specified under OAR 333-061-0042(3)
Date issued:
2026
Regulatory references:
OAR 333-061-0040(1), OAR 333-061-0042(3-4)
Distribution methods:
Hand delivery, mail, posting in public locations, additional outreach methods
Health advisory included:
Yes, mandatory language for health effects in italics